| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |